Home Newsmakers Leukemia & Lymphoma Society allocates $4.5M for blood cancer patients during pandemic

Leukemia & Lymphoma Society allocates $4.5M for blood cancer patients during pandemic

SHARE

“Cancer doesn’t stop because of COVID-19” said LLS chief executive Louis J. DeGennaro,

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email